ATRO.NASDAQAstronics CORP

Form 4: Astronics Executive Peabody Receives New RSU Grant

Sentiment:

Statement of Changes in Beneficial Ownership

📋All filings for Astronics CORP
🔒Login to Follow

Astronics Corp.'s Executive VP Mark Peabody was granted 7,675 restricted stock units, with vesting tied to the company's adjusted EBITDA performance through 2028.

Summary

  • Mark Peabody, Executive VP & President-Aerospace of Astronics Corp. (ATRO), reported changes in his beneficial ownership.
  • On February 19, 2026, Peabody was granted 7,675 Restricted Stock Units (RSUs) as part of his compensation.
  • These new RSUs are performance-based, with vesting contingent on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2026, through December 31, 2028.
  • The target number of RSUs is 7,675, but the actual number vesting can range from 50% to 150% of this target, based on actual performance against the EBITDA goal.
  • Vesting for these specific RSUs is scheduled for February 19, 2029.
  • Peabody also holds other non-derivative securities, including 54,174.73 shares of Common Stock and 183,445 shares of Class B Stock.
  • Existing derivative holdings include various stock options with exercise prices ranging from $9.74 to $35.61 and expiration dates up to December 16, 2032.
  • Other outstanding RSU grants (15,900, 10,850, and 15,150 target units) are also performance-based, tied to different EBITDA periods and vesting dates between February 2026 and February 2028.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive development, as it represents a standard executive compensation grant that aligns management's long-term interests with shareholder value through performance-based incentives.

Positives

  • The grant of performance-based Restricted Stock Units (RSUs) aligns executive compensation with the company's financial performance, specifically adjusted EBITDA, encouraging management to drive profitability.
  • The potential for vesting between 50% and 150% of the target units provides a strong incentive for management to achieve and exceed performance goals, directly benefiting shareholders.

Risks

  • The vesting of a significant portion of executive compensation (RSUs) is tied to Astronics Corp.'s average annual adjusted EBITDA, meaning if the company's financial performance does not meet targets, the executive may receive fewer shares, potentially impacting long-term retention if targets are consistently missed.
  • The long vesting periods (up to February 2029 for the latest grant) expose the executive to long-term market and operational risks of the company, which could affect the ultimate value of the compensation.

Future Outlook

The filing indicates a forward-looking compensation structure for executive Mark Peabody, with a significant portion of his equity awards (Restricted Stock Units) tied to Astronics Corp.'s future average annual adjusted EBITDA performance. These performance periods extend through December 31, 2028, with vesting dates as late as February 19, 2029, demonstrating a long-term incentive strategy aimed at aligning executive interests with sustained company profitability.

Industry Context

StockSavvy.ai notes that performance-based equity awards, such as the Restricted Stock Units granted to Mark Peabody, are a common and increasingly preferred method of executive compensation in the aerospace and defense industry. This structure aligns management's financial incentives directly with the company's operational and financial success, particularly metrics like EBITDA, which are critical indicators of profitability and cash flow generation in capital-intensive sectors. This practice is consistent with broader corporate governance trends emphasizing pay-for-performance.

Comparison to Industry Standards

  • The use of adjusted EBITDA as a performance metric for RSU vesting is a standard practice in the aerospace and defense industry, similar to companies like Boeing, Raytheon Technologies, and Lockheed Martin, which often tie executive incentives to operational profitability and and cash flow.
  • The vesting range of 50% to 150% (or 75% to 115% for some grants) of target units is within typical industry ranges for performance-based equity, designed to reward strong performance while penalizing underperformance.
  • The multi-year performance periods (e.g., 2026-2028) and long vesting schedules (up to 2029) are consistent with long-term incentive plans seen across comparable industrial and technology companies, encouraging sustained strategic focus rather than short-term gains.

Related Party Transactions

  • The grant of Restricted Stock Units (RSUs) to Executive VP Mark Peabody constitutes an executive compensation arrangement, which is a common form of related party transaction between a company and its officers.

Stakeholder Impact

  • Shareholders: The performance-based nature of the RSU grants aligns executive incentives with shareholder interests, potentially leading to improved company performance and increased shareholder value if EBITDA targets are met or exceeded.
  • Management: Mark Peabody's future compensation is directly tied to the company's financial performance, providing a strong incentive for strategic execution and operational efficiency.

Next Steps

  • Astronics Corp.'s management will continue to focus on achieving average annual adjusted EBITDA targets for the periods ending December 31, 2025, December 31, 2026, December 31, 2027, and December 31, 2028, to maximize RSU vesting for executives.
  • The various tranches of Restricted Stock Units (RSUs) held by Mark Peabody are scheduled to vest on February 23, 2026, February 22, 2027, February 27, 2028, and February 19, 2029, contingent on performance.
  • Existing stock options held by Mark Peabody will remain exercisable until their respective expiration dates, ranging from December 14, 2026, to December 7, 2033.

Key Dates

DateDescription
12/14/2017Date exercisable for options with $31.76 exercise price.
12/12/2018Date exercisable for options with $35.61 exercise price.
12/13/2019Date exercisable for options with $31.57 exercise price.
12/09/2020Date exercisable for options with $30.04 exercise price.
01/22/2022Date exercisable for options with $14.45 exercise price.
12/09/2022Date exercisable for options with $11.13 exercise price.
12/16/2023Date exercisable for options with $9.74 exercise price.
01/01/2023Start of performance period for 10,850 target RSUs.
12/07/2024Date exercisable for options with $15.15 exercise price.
01/01/2024Start of performance period for 15,900 target RSUs.
01/01/2025Start of performance period for 15,150 target RSUs.
12/31/2025End of performance period for 10,850 target RSUs.
02/19/2026Transaction date for the acquisition of 7,675 new Restricted Stock Units (RSUs) and start of performance period for these RSUs.
02/23/2026Vesting date for 10,850 target RSUs.
02/23/2026Signature date of the filing by Power of Attorney for Mark Peabody.
12/14/2026Expiration date for options with $31.76 exercise price.
12/31/2026End of performance period for 15,900 target RSUs.
02/22/2027Vesting date for 15,900 target RSUs.
12/12/2027Expiration date for options with $35.61 exercise price.
12/31/2027End of performance period for 15,150 target RSUs.
02/27/2028Vesting date for 15,150 target RSUs.
12/31/2028End of performance period for 7,675 new RSUs.
12/13/2028Expiration date for options with $31.57 exercise price.
02/19/2029Vesting date for 7,675 new RSUs.
12/09/2029Expiration date for options with $30.04 exercise price.
01/22/2031Expiration date for options with $14.45 exercise price.
12/09/2031Expiration date for options with $11.13 exercise price.
12/16/2032Expiration date for options with $9.74 exercise price.
12/07/2033Expiration date for options with $15.15 exercise price.

Recommendation

hold

This Form 4 filing reports a routine executive compensation grant and does not contain information that would fundamentally alter the investment thesis for Astronics Corp. While the performance-based nature of the RSUs is a positive for aligning management incentives, it is a standard practice and not a catalyst for a 'buy' or 'sell' recommendation. Investors should 'hold' and continue to monitor the company's broader financial performance and strategic developments.

Keywords

Astronics Corp, ATRO, Mark Peabody, SEC Form 4, Restricted Stock Units, RSU, Executive Compensation, Insider Trading, EBITDA, Performance-based compensation, Stock Options, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.